Protocols
1 protocol(s) meet the specified criteria
Drug: GSK2857916
Protocol No.TitleStatus
BMA117159A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of the Antibody Drug Conjugate GSK2857916 in Subjects with Relapsed/Refractory Multiple Myeloma and Other Advanced Hematologic malignancies Expressing BCMAOpen